Market Overview:
The global clinical research organisation (CRO) market is expected to grow at a CAGR of 7.5% from 2018 to 2030. The growth in the CRO market can be attributed to the increasing number of clinical trials, rising demand for contract research services, and growing focus on outsourcing by pharmaceutical and biotechnology companies. The CRO market is segmented on the basis of type into small molecules and biologics. The small molecules segment is expected to account for the majority share of the CRO market in 2018. However, the biologics segment is projected to grow at a higher CAGR during the forecast period owing to increasing demand for novel therapies and rising prevalence of chronic diseases. On the basis of application,the CRO market is divided into three segments: pharmaceutical companies, research institutes, and other end users such as medical device manufacturers and academic institutions. Pharmaceutical companies are expected to account forthe largest shareof th eCR Omarketin2018 .
 Industry Outlook.svg)
Product Definition:
A clinical research organisation (CRO) is a company or institution that conducts clinical trials on behalf of pharmaceutical, biotechnology, and medical device companies. The CRO industry has exploded in recent years as the number of drug and device approvals by the U.S. Food and Drug Administration (FDA) has increased.
The use of CROs allows pharmaceutical, biotechnology, and medical device companies to focus on their core competencies – developing new drugs and devices – while outsourcing much of the work associated with conducting clinical trials.
Small molecules:
Small molecules are the most commonly used drug ingredients. They account for more than 90% of all pharmaceutical drugs. Small molecules can be administered to patients in various forms such as tablets, injections, and inhalation solutions.
The global small molecule's market is expected to grow at a CAGR of XX% during the forecast period owing to increasing R&D activities by major companies.
Biologics:
Biologics are living organisms or products derived from living organisms and used as therapeutic agents. They are different from conventional drugs as they have a unique mechanism of action, grow in nature and can only be obtained from the original source (biological source) or through biotechnology.
The global CRO market size was valued at USD 21 billion in 2015 and is expected to grow at a CAGR of XX% over the forecast period.
Application Insights:
The pharmaceutical company segment dominated the global CRO market in 2017. This is attributed to factors such as presence of a strong pipeline and presence of key products in the pipeline that are ready for clinical trials. For instance, according to data published by WHO, around 10-20% of drugs developed complete clinical testing every year. Similarly, according to an article published by Statista in 2018, around 20% - 25% of all medicines developed have completed Phase III clinical trials and are ready for commercialization. These factors indicate that there is ample scope for growth over the forecast period for this segment.
However, other segments such as research institutes and others also exhibit significant potential growth owing to increasing government funding towards R&D activities coupled with growing awareness about advanced treatments among patients globally (through various media outlets).
Regional Analysis:
North America dominated the global market in 2017. This can be attributed to the presence of a large number of CROs, increasing outsourcing activities by North American CROs, and high healthcare expenditure in this region. Moreover, growing focus on clinical trials for new drug development is expected to drive regional growth over the forecast period.
Asia Pacific is anticipated to witness lucrative growth during the forecast period owing to rising investments by global players for expanding their commercial reach and improving their revenue margins from low-cost countries such as India and China. In addition, government initiatives encouraging domestic level R&D are expected to fuel regional demand during the forecast period.
Growth Factors:
- Increasing demand for clinical research services due to the increase in number of drug approvals by the USFDA and other regulatory agencies across the globe.
- Growing demand for contract research services from biotechnology and pharmaceutical companies due to their focus on core competencies.
- Proliferation of clinical trials owing to increasing prevalence of chronic diseases, such as cancer, diabetes, and cardiovascular diseases.
- Rising public-private investments in life sciences sector that is fuelling the growth of CROs worldwide
Scope Of The Report
Report Attributes
Report Details
Report Title
Clinical Research Organisation (CRO) Market Research Report
By Type
Small molecules, Biologics
By Application
Pharmaceutical Company, Research Institute, Other
By Companies
Charles River Laboratories, IQVIA, LabCorp, Domainex, Evotec AG, Genscript Biotech, GVK Biosciences, Aurobindo Pharma, Eurofins Scientific, Reprocell, Dalton Pharma, NovAliX, Jubilant Biosys, Lupin Pharmaceuticals, Piramal Pharma, Sun Pharmaceutical, Sai Ganga Panakeia, Vitas Pharma, Pharmaron Beijing, WuXi AppTec, Asymchem Laboratories, Porton Pharma, ChemPartner, Hangzhou Tigermed
Regions Covered
North America, Europe, APAC, Latin America, MEA
Base Year
2021
Historical Year
2019 to 2020 (Data from 2010 can be provided as per availability)
Forecast Year
2030
Number of Pages
233
Number of Tables & Figures
164
Customization Available
Yes, the report can be customized as per your need.
Global Clinical Research Organisation (CRO) Market Report Segments:
The global Clinical Research Organisation (CRO) market is segmented on the basis of:
Types
Small molecules, Biologics
The product segment provides information about the market share of each product and the respective CAGR during the forecast period. It lays out information about the product pricing parameters, trends, and profits that provides in-depth insights of the market. Furthermore, it discusses latest product developments & innovation in the market.
Applications
Pharmaceutical Company, Research Institute, Other
The application segment fragments various applications of the product and provides information on the market share and growth rate of each application segment. It discusses the potential future applications of the products and driving and restraining factors of each application segment.
Some of the companies that are profiled in this report are:
- Charles River Laboratories
- IQVIA
- LabCorp
- Domainex
- Evotec AG
- Genscript Biotech
- GVK Biosciences
- Aurobindo Pharma
- Eurofins Scientific
- Reprocell
- Dalton Pharma
- NovAliX
- Jubilant Biosys
- Lupin Pharmaceuticals
- Piramal Pharma
- Sun Pharmaceutical
- Sai Ganga Panakeia
- Vitas Pharma
- Pharmaron Beijing
- WuXi AppTec
- Asymchem Laboratories
- Porton Pharma
- ChemPartner
- Hangzhou Tigermed
 Market Overview.svg)
Highlights of The Clinical Research Organisation (CRO) Market Report:
- The market structure and projections for the coming years.
- Drivers, restraints, opportunities, and current trends of market.
- Historical data and forecast.
- Estimations for the forecast period 2030.
- Developments and trends in the market.
- By Type:
- Small molecules
- Biologics
- By Application:
- Pharmaceutical Company
- Research Institute
- Other
- Market scenario by region, sub-region, and country.
- Market share of the market players, company profiles, product specifications, SWOT analysis, and competitive landscape.
- Analysis regarding upstream raw materials, downstream demand, and current market dynamics.
- Government Policies, Macro & Micro economic factors are also included in the report.
We have studied the Clinical Research Organisation (CRO) Market in 360 degrees via. both primary & secondary research methodologies. This helped us in building an understanding of the current market dynamics, supply-demand gap, pricing trends, product preferences, consumer patterns & so on. The findings were further validated through primary research with industry experts & opinion leaders across countries. The data is further compiled & validated through various market estimation & data validation methodologies. Further, we also have our in-house data forecasting model to predict market growth up to 2030.
Regional Analysis
- North America
- Europe
- Asia Pacific
- Middle East & Africa
- Latin America
Note: A country of choice can be added in the report at no extra cost. If more than one country needs to be added, the research quote will vary accordingly.
The geographical analysis part of the report provides information about the product sales in terms of volume and revenue in regions. It lays out potential opportunities for the new entrants, emerging players, and major players in the region. The regional analysis is done after considering the socio-economic factors and government regulations of the countries in the regions.
How you may use our products:
- Correctly Positioning New Products
- Market Entry Strategies
- Business Expansion Strategies
- Consumer Insights
- Understanding Competition Scenario
- Product & Brand Management
- Channel & Customer Management
- Identifying Appropriate Advertising Appeals
 Market Statistics.svg)
8 Reasons to Buy This Report
- Includes a Chapter on the Impact of COVID-19 Pandemic On the Market
- Report Prepared After Conducting Interviews with Industry Experts & Top Designates of the Companies in the Market
- Implemented Robust Methodology to Prepare the Report
- Includes Graphs, Statistics, Flowcharts, and Infographics to Save Time
- Industry Growth Insights Provides 24/5 Assistance Regarding the Doubts in the Report
- Provides Information About the Top-winning Strategies Implemented by Industry Players.
- In-depth Insights On the Market Drivers, Restraints, Opportunities, and Threats
- Customization of the Report Available
Frequently Asked Questions?
A Clinical Research Organisation (CRO) is a company or organisation that conducts clinical trials.
Some of the major players in the clinical research organisation (cro) market are Charles River Laboratories, IQVIA, LabCorp, Domainex, Evotec AG, Genscript Biotech, GVK Biosciences, Aurobindo Pharma, Eurofins Scientific, Reprocell, Dalton Pharma, NovAliX, Jubilant Biosys, Lupin Pharmaceuticals, Piramal Pharma, Sun Pharmaceutical, Sai Ganga Panakeia, Vitas Pharma, Pharmaron Beijing, WuXi AppTec, Asymchem Laboratories, Porton Pharma, ChemPartner, Hangzhou Tigermed.
The clinical research organisation (cro) market is expected to register a CAGR of 7.5%.
Chapter 1 Executive Summary
Chapter 2 Assumptions and Acronyms Used
Chapter 3 Research Methodology
Chapter 4 Clinical Research Organisation (CRO) Market Overview
4.1 Introduction
4.1.1 Market Taxonomy
4.1.2 Market Definition
4.1.3 Macro-Economic Factors Impacting the Market Growth
4.2 Clinical Research Organisation (CRO) Market Dynamics
4.2.1 Market Drivers
4.2.2 Market Restraints
4.2.3 Market Opportunity
4.3 Clinical Research Organisation (CRO) Market - Supply Chain Analysis
4.3.1 List of Key Suppliers
4.3.2 List of Key Distributors
4.3.3 List of Key Consumers
4.4 Key Forces Shaping the Clinical Research Organisation (CRO) Market
4.4.1 Bargaining Power of Suppliers
4.4.2 Bargaining Power of Buyers
4.4.3 Threat of Substitution
4.4.4 Threat of New Entrants
4.4.5 Competitive Rivalry
4.5 Global Clinical Research Organisation (CRO) Market Size & Forecast, 2018-2028
4.5.1 Clinical Research Organisation (CRO) Market Size and Y-o-Y Growth
4.5.2 Clinical Research Organisation (CRO) Market Absolute $ Opportunity
Chapter 5 Global Clinical Research Organisation (CRO) Market Analysis and Forecast by Type
5.1 Introduction
5.1.1 Key Market Trends & Growth Opportunities by Type
5.1.2 Basis Point Share (BPS) Analysis by Type
5.1.3 Absolute $ Opportunity Assessment by Type
5.2 Clinical Research Organisation (CRO) Market Size Forecast by Type
5.2.1 Small molecules
5.2.2 Biologics
5.3 Market Attractiveness Analysis by Type
Chapter 6 Global Clinical Research Organisation (CRO) Market Analysis and Forecast by Applications
6.1 Introduction
6.1.1 Key Market Trends & Growth Opportunities by Applications
6.1.2 Basis Point Share (BPS) Analysis by Applications
6.1.3 Absolute $ Opportunity Assessment by Applications
6.2 Clinical Research Organisation (CRO) Market Size Forecast by Applications
6.2.1 Pharmaceutical Company
6.2.2 Research Institute
6.2.3 Other
6.3 Market Attractiveness Analysis by Applications
Chapter 7 Global Clinical Research Organisation (CRO) Market Analysis and Forecast by Region
7.1 Introduction
7.1.1 Key Market Trends & Growth Opportunities by Region
7.1.2 Basis Point Share (BPS) Analysis by Region
7.1.3 Absolute $ Opportunity Assessment by Region
7.2 Clinical Research Organisation (CRO) Market Size Forecast by Region
7.2.1 North America
7.2.2 Europe
7.2.3 Asia Pacific
7.2.4 Latin America
7.2.5 Middle East & Africa (MEA)
7.3 Market Attractiveness Analysis by Region
Chapter 8 Coronavirus Disease (COVID-19) Impact
8.1 Introduction
8.2 Current & Future Impact Analysis
8.3 Economic Impact Analysis
8.4 Government Policies
8.5 Investment Scenario
Chapter 9 North America Clinical Research Organisation (CRO) Analysis and Forecast
9.1 Introduction
9.2 North America Clinical Research Organisation (CRO) Market Size Forecast by Country
9.2.1 U.S.
9.2.2 Canada
9.3 Basis Point Share (BPS) Analysis by Country
9.4 Absolute $ Opportunity Assessment by Country
9.5 Market Attractiveness Analysis by Country
9.6 North America Clinical Research Organisation (CRO) Market Size Forecast by Type
9.6.1 Small molecules
9.6.2 Biologics
9.7 Basis Point Share (BPS) Analysis by Type
9.8 Absolute $ Opportunity Assessment by Type
9.9 Market Attractiveness Analysis by Type
9.10 North America Clinical Research Organisation (CRO) Market Size Forecast by Applications
9.10.1 Pharmaceutical Company
9.10.2 Research Institute
9.10.3 Other
9.11 Basis Point Share (BPS) Analysis by Applications
9.12 Absolute $ Opportunity Assessment by Applications
9.13 Market Attractiveness Analysis by Applications
Chapter 10 Europe Clinical Research Organisation (CRO) Analysis and Forecast
10.1 Introduction
10.2 Europe Clinical Research Organisation (CRO) Market Size Forecast by Country
10.2.1 Germany
10.2.2 France
10.2.3 Italy
10.2.4 U.K.
10.2.5 Spain
10.2.6 Russia
10.2.7 Rest of Europe
10.3 Basis Point Share (BPS) Analysis by Country
10.4 Absolute $ Opportunity Assessment by Country
10.5 Market Attractiveness Analysis by Country
10.6 Europe Clinical Research Organisation (CRO) Market Size Forecast by Type
10.6.1 Small molecules
10.6.2 Biologics
10.7 Basis Point Share (BPS) Analysis by Type
10.8 Absolute $ Opportunity Assessment by Type
10.9 Market Attractiveness Analysis by Type
10.10 Europe Clinical Research Organisation (CRO) Market Size Forecast by Applications
10.10.1 Pharmaceutical Company
10.10.2 Research Institute
10.10.3 Other
10.11 Basis Point Share (BPS) Analysis by Applications
10.12 Absolute $ Opportunity Assessment by Applications
10.13 Market Attractiveness Analysis by Applications
Chapter 11 Asia Pacific Clinical Research Organisation (CRO) Analysis and Forecast
11.1 Introduction
11.2 Asia Pacific Clinical Research Organisation (CRO) Market Size Forecast by Country
11.2.1 China
11.2.2 Japan
11.2.3 South Korea
11.2.4 India
11.2.5 Australia
11.2.6 South East Asia (SEA)
11.2.7 Rest of Asia Pacific (APAC)
11.3 Basis Point Share (BPS) Analysis by Country
11.4 Absolute $ Opportunity Assessment by Country
11.5 Market Attractiveness Analysis by Country
11.6 Asia Pacific Clinical Research Organisation (CRO) Market Size Forecast by Type
11.6.1 Small molecules
11.6.2 Biologics
11.7 Basis Point Share (BPS) Analysis by Type
11.8 Absolute $ Opportunity Assessment by Type
11.9 Market Attractiveness Analysis by Type
11.10 Asia Pacific Clinical Research Organisation (CRO) Market Size Forecast by Applications
11.10.1 Pharmaceutical Company
11.10.2 Research Institute
11.10.3 Other
11.11 Basis Point Share (BPS) Analysis by Applications
11.12 Absolute $ Opportunity Assessment by Applications
11.13 Market Attractiveness Analysis by Applications
Chapter 12 Latin America Clinical Research Organisation (CRO) Analysis and Forecast
12.1 Introduction
12.2 Latin America Clinical Research Organisation (CRO) Market Size Forecast by Country
12.2.1 Brazil
12.2.2 Mexico
12.2.3 Rest of Latin America (LATAM)
12.3 Basis Point Share (BPS) Analysis by Country
12.4 Absolute $ Opportunity Assessment by Country
12.5 Market Attractiveness Analysis by Country
12.6 Latin America Clinical Research Organisation (CRO) Market Size Forecast by Type
12.6.1 Small molecules
12.6.2 Biologics
12.7 Basis Point Share (BPS) Analysis by Type
12.8 Absolute $ Opportunity Assessment by Type
12.9 Market Attractiveness Analysis by Type
12.10 Latin America Clinical Research Organisation (CRO) Market Size Forecast by Applications
12.10.1 Pharmaceutical Company
12.10.2 Research Institute
12.10.3 Other
12.11 Basis Point Share (BPS) Analysis by Applications
12.12 Absolute $ Opportunity Assessment by Applications
12.13 Market Attractiveness Analysis by Applications
Chapter 13 Middle East & Africa (MEA) Clinical Research Organisation (CRO) Analysis and Forecast
13.1 Introduction
13.2 Middle East & Africa (MEA) Clinical Research Organisation (CRO) Market Size Forecast by Country
13.2.1 Saudi Arabia
13.2.2 South Africa
13.2.3 UAE
13.2.4 Rest of Middle East & Africa (MEA)
13.3 Basis Point Share (BPS) Analysis by Country
13.4 Absolute $ Opportunity Assessment by Country
13.5 Market Attractiveness Analysis by Country
13.6 Middle East & Africa (MEA) Clinical Research Organisation (CRO) Market Size Forecast by Type
13.6.1 Small molecules
13.6.2 Biologics
13.7 Basis Point Share (BPS) Analysis by Type
13.8 Absolute $ Opportunity Assessment by Type
13.9 Market Attractiveness Analysis by Type
13.10 Middle East & Africa (MEA) Clinical Research Organisation (CRO) Market Size Forecast by Applications
13.10.1 Pharmaceutical Company
13.10.2 Research Institute
13.10.3 Other
13.11 Basis Point Share (BPS) Analysis by Applications
13.12 Absolute $ Opportunity Assessment by Applications
13.13 Market Attractiveness Analysis by Applications
Chapter 14 Competition Landscape
14.1 Clinical Research Organisation (CRO) Market: Competitive Dashboard
14.2 Global Clinical Research Organisation (CRO) Market: Market Share Analysis, 2019
14.3 Company Profiles (Details – Overview, Financials, Developments, Strategy)
14.3.1 Charles River Laboratories
14.3.2 IQVIA
14.3.3 LabCorp
14.3.4 Domainex
14.3.5 Evotec AG
14.3.6 Genscript Biotech
14.3.7 GVK Biosciences
14.3.8 Aurobindo Pharma
14.3.9 Eurofins Scientific
14.3.10 Reprocell
14.3.11 Dalton Pharma
14.3.12 NovAliX
14.3.13 Jubilant Biosys
14.3.14 Lupin Pharmaceuticals
14.3.15 Piramal Pharma
14.3.16 Sun Pharmaceutical
14.3.17 Sai Ganga Panakeia
14.3.18 Vitas Pharma
14.3.19 Pharmaron Beijing
14.3.20 WuXi AppTec
14.3.21 Asymchem Laboratories
14.3.22 Porton Pharma
14.3.23 ChemPartner
14.3.24 Hangzhou Tigermed
